Atjaunināt sīkdatņu piekrišanu

E-grāmata: Mechanical Circulatory Support in End-Stage Heart Failure: A Practical Manual

Edited by , Edited by , Edited by , Contributions by , Edited by , Edited by
  • Formāts: EPUB+DRM
  • Izdošanas datums: 14-Jul-2017
  • Izdevniecība: Springer International Publishing AG
  • Valoda: eng
  • ISBN-13: 9783319433837
Citas grāmatas par šo tēmu:
  • Formāts - EPUB+DRM
  • Cena: 165,96 €*
  • * ši ir gala cena, t.i., netiek piemērotas nekādas papildus atlaides
  • Ielikt grozā
  • Pievienot vēlmju sarakstam
  • Šī e-grāmata paredzēta tikai personīgai lietošanai. E-grāmatas nav iespējams atgriezt un nauda par iegādātajām e-grāmatām netiek atmaksāta.
  • Formāts: EPUB+DRM
  • Izdošanas datums: 14-Jul-2017
  • Izdevniecība: Springer International Publishing AG
  • Valoda: eng
  • ISBN-13: 9783319433837
Citas grāmatas par šo tēmu:

DRM restrictions

  • Kopēšana (kopēt/ievietot):

    nav atļauts

  • Drukāšana:

    nav atļauts

  • Lietošana:

    Digitālo tiesību pārvaldība (Digital Rights Management (DRM))
    Izdevējs ir piegādājis šo grāmatu šifrētā veidā, kas nozīmē, ka jums ir jāinstalē bezmaksas programmatūra, lai to atbloķētu un lasītu. Lai lasītu šo e-grāmatu, jums ir jāizveido Adobe ID. Vairāk informācijas šeit. E-grāmatu var lasīt un lejupielādēt līdz 6 ierīcēm (vienam lietotājam ar vienu un to pašu Adobe ID).

    Nepieciešamā programmatūra
    Lai lasītu šo e-grāmatu mobilajā ierīcē (tālrunī vai planšetdatorā), jums būs jāinstalē šī bezmaksas lietotne: PocketBook Reader (iOS / Android)

    Lai lejupielādētu un lasītu šo e-grāmatu datorā vai Mac datorā, jums ir nepieciešamid Adobe Digital Editions (šī ir bezmaksas lietotne, kas īpaši izstrādāta e-grāmatām. Tā nav tas pats, kas Adobe Reader, kas, iespējams, jau ir jūsu datorā.)

    Jūs nevarat lasīt šo e-grāmatu, izmantojot Amazon Kindle.

This book is a detailed practical guide to the use of ventricular assist devices and total artificial hearts to provide mechanical circulatory support (MCS) in patients with end-stage heart failure. It explains why MCS may be indicated, which patients require MCS, when and how to implant ventricular assist devices or a total artificial heart, and how to avoid potential complications of MCS. Management throughout the period of care is described, from preimplantation to follow-up, and both typical and atypical cases are discussed. The text features numerous helpful tips and tricks relating to surgical and nonsurgical management and is supported by a wealth of high-quality illustrations that document preoperative evaluation and implantation technique. Heart transplantation remains the gold standard for the treatment of patients suffering from end-stage heart failure, but the shortage of donors has led to an increase in the use of MCS. This book will assist all physicians, and especia

lly cardiologists and anesthesiologists, who are involved in the care of these patients.

PART I: PREOPERATIVE EVALUATION - 1 Physiopathology and Fate of End-Stage Cardiac Heart Failure in the era of Mechanical Circulatory Support.- 2 The Advantage of Mechanical Solution: Results of Clinical Trials to Date.- 3 Mechanical Circulatory Support Candidate Selection Criteria.- 4 Preoperative Assessment and Clinical Optimization.- 5 Preoperative Evaluation of Right Ventricular Function.- 6 High INTERMACS profiles: Medical vs. Mechanical Circulatory Support treatment.- 7 Low INTERMACS Profiles: which Strategies? (Temporary ECMO or TAH support; Temporary mid-term Paracorporeal Ventricular Assisted Device Support; Primary long-term Ventricular Assisted Device placement).- 8 From BTT to DT Strategy: USA and Europe views.- 9 Mechanical Circulatory Support as a Bridge to Recovery.- 10 Mechanical Circulatory Support as a Bridge to Candidacy.- PART II: INTRAOPERATIVE TIPS AND PITFALLS - 11 Pulsatile vs. Continuous Flow pumps: Engineering and Clinical Considerations.- 12 Which Approac

h? Traditional vs. MICS.- 13 To Pump or not to Pump: the Role of Cardio-Pulmonary Bypass or ECMO.- 14 Techniques for Inflow Cannula Placement.- 15 Techniques for Outflow Cannula Placement.- 16 Techniques for Driveline Positioning.- 17 Percutaneous Devices: Options.- 18 Paracorporeal Biventricular Devices.- 19 Biventricular Implantable Continuous flow pumps.- 20 The Total Artificial Heart.- 21 Mechanical Circulatory Support in Pediatric Population.- 22 Concomitant Cardiac Surgery during Ventricular Assisted Device Placement: When is It too Much .- 23 Pump Removal after Recovery.- 24 Intraoperative anesthesiological monitoring and management.- 25 Intraoperative right ventricular failure management.- PART III: POSTOPERATIVE RECOMMENDATIONS - 26 Physiotherapy and Rehabilitation Management in Ventricular Assisted Device Patients.- 27 Coagulation Monitoring.- 28 Adverse events management: Ischemic and Haemorragic Stroke.- 29 Adverse events management: Gastro-intestinal Bleeding.- 30 Adv

erse events management: Pump Thrombosis.- 31 Adverse events management: Infectious Complications.- 32 Adverse events management: AVW Syndrome.- 33 Adverse events management: Concomitant non-Cardiac Surgery during MCS: Management of Therapy.- 34 Pump and Equipment Failure: How to Behave.- 35 The Outpatient Care: The Role of Ventricular Assisted Device coordinator and the Remote Monitoring.- PART IV: MISCELLANEA - 36. Miniaturization and Future Technologies.- 37 ReliantHeart - Forward Compatibility and TET.- 38 The BIVACOR project.- 39 Potential of CARMAT in the Future.- 40 The ReinHeart Solution.- 41 Ethical and Psychological aspects of long-term MCS.- 42 Health-Economic Aspects of Mechanlical Circulatory Support Therapy.- 43 The Mechanical Circulatory Support Registries: Role and Perspectives.- 44 Conclusions.
1 Invited Lecture "Pioneering the Future: From Transplant to Device Development"
1(12)
O.H. Frazier
I Preoperative Evaluation
2 Physiopathology and Fate of End-Stage CHF in the Era of MCS
13(12)
Vito Piazza
A. Montalto
C. Amarelli
A. Loforte
Francesco Musumeci
3 Cardiomyopathies and Clinical Features
25(12)
F. Grigioni
L. Potena
G. Marinelli
Marco Masetti
4 MCS Candidate Selection Criteria
37(22)
Cristiano Amarelli
Marianna Buonocore
Ciro Maiello
Andrea Montalto
Georg Wieselthaler
5 Preoperative Assessment and Clinical Optimization
59(16)
Maria Frigerio
Manlio Cipriani
Fabrizio Oliva
Federico Pappalardo
6 Preoperative Evaluation of Right Ventricular Function
75(18)
Michael Dandel
Evgenij V. Potapov
Nader Moazami
7 High INTERMACS Profiles: Medical Versus MCS Treatment
93(10)
A. Barbone
Bart P. Meyns
8 Low INTERMACS Profiles: Temporary ECMO or TAH Support
103(4)
V. Tarzia
G. Bortolussi
Lorenzo Bagozzi
T. Bottio
G. Gerosa
9 Low INTERMACS Profiles: Temporary Midterm Paracorporeal VAD Support
107(8)
Steven Tsui
Colleen Pietras
David L. Joyce
10 Low INTERMACS Profiles: One-Stage Durable LVAD Implantation for INTERMACS Level 1: Indications and Contraindications
115(6)
Daisuke Yoshioka
Koji Takeda
Hiroo Takayama
Yoshifumi Naka
11 Bridge to Transplant and Destination Therapy Strategies in the United States
121(10)
Yasuhiro Shudo
Hanjay Wang
Andrew B. Goldstone
Y. Joseph Woo
12 Mechanical Circulatory Support as Bridge to Recovery
131(18)
Michael Dandel
Stephan Schueler
13 Mechanical Circulatory Support as Bridge to Candidacy
149(14)
Maria Frigerio
Manlio Cipriani
David Feldman
II Intraoperative Tips and Pitfalls
14 Engineering and Clinical Considerations in Rotary Blood Pumps
163(12)
F. Moscato
H. Schima
15 Engineering and Clinical Considerations in Pulsatile Blood Pump
175(8)
Oliver Voigt
Friedrich Kaufmann
16 Intraoperative Anesthesiological Monitoring and Management
183(10)
M. Baiocchi
M. Benedetto
G. Frascaroli
17 Transesophageal Echocardiography During LVAD Implantation
193(8)
Marian Kukucka
18 Intraoperative Anticoagulation and Coagulation Management
201(10)
Andreas Koster
Federico Pappalardo
19 Intraoperative Right Ventricular Failure Management
211(10)
Matteo Attisani
Paolo Centofanti
Mauro Rinaldi
20 Tricuspid Valve Regurgitation and Right Ventricular Dysfunction During Left Ventricular Assist Device Implantation
221(6)
Paul C. Tang
Alina Nicoara
Carmelo A. Milano
21 Role of Inotropes, Pulmonary Vasodilators, and Other Pharmacologic Interventions for Right Ventricular Dysfunction
227(8)
Diyar Saeed
22 Temporary RVAD
235(6)
Alexander Stepanenko
23 Which Approach? Traditional Versus MICS
241(12)
Sebastian V. Rojas
Jasmin S. Hanke
Ezin Deniz
Christina Feldmann
Axel Haverich
Thomas Krabatsch
Evgenij Potapov
Daniel Zimpfer
Simon Maltais
Jan D. Schmitto
24 Minimal Invasive: Padua's Approach and Technique
253(12)
Tomaso Bottio
Jonida Bejko
Vincenzo Tarzia
Gino Gerosa
25 To Pump or Not to Pump: The Role of CPB or ECMO
265(6)
Daniel Zimpfer
26 Techniques for Inflow Cannula Placement
271(6)
Nicolas A. Brozzi
Antonio Loforte
Matthias Loebe
27 Techniques for Outflow Cannula Placement
277(4)
Antonio Loforte
Arnt E. Fiane
28 Techniques for Driveline Positioning
281(6)
Christina Feldmann
Jasmin S. Hanke
Gunes Dogan
Ezin Deniz
Axel Haverich
Thomas Krabatsch
Jan D. Schmitto
29 Percutaneous Devices: Options
287(12)
Melody Sherwood
Shelley A. Hall
30 Paracorporeal Biventricular Assist Devices: The EXCOR® VAD System
299(6)
Ares K. Menon
S. Ersel
31 Biventricular Circulatory Support with Two Implantable Continuous-Flow Pumps
305(8)
Thomas Krabatsch
32 The Total Artificial Heart
313(24)
Jack Copeland
Francisco A. Arabia
Gero Tenderich
Antonella Marino
Oliver Voigt
Ciro Maiello
Cristiano Amarelli
33 Concomitant Cardiac Surgery During VAD Placement: When Is It Too Much?
337(12)
Walter P. Dembistky
Karl K. Limmer
Robert M. Adamson
34 Pump Removal After Myocardial Recovery During Left Ventricular Assist Device Support
349(6)
E. Potapov
M. Kukucka
T. Krabatsch
III MCS in Pediatric Population
35 Mechanical Circulatory Support in Pediatric Population: Clinical Considerations, Indications, Strategies, and Postoperative Management
355(6)
O. Miera
F. Berger
K.R. Schmitt
36 Continuous-Flow Pumps in Pediatric Population
361(10)
Martin Schweiger
Daniel Zimpfer
Gaetano Gargiulo
Michael Hubler
37 The Berlin Heart EXCOR Experience in the USA
371(10)
Chet R. Villa
David L.S. Morales
38 Ventricular Assist Device Support for Hypoplastic Left Heart Syndrome, Fontan Failure, and End-Stage Systemic Right Ventricular Dysfunction
381(10)
Fabrizio De Rita
Antonio Amodeo
Asif Hasan
39 Continuous-Flow Pumps in Infants, Jarvik Infant System, and Destination Therapy in Pediatrics
391(12)
Antonio Amodeo
Sergio Filippelli
Arianna Di Molfetta
Gianluigi Perri
R. Jarvik
IV Postoperative Recommendations
40 Physiotherapy and Rehabilitation Management in Adult LVAD Patients
403(18)
L. Compostella
M. Polastri
M. Lamotte
Fabio Bellotto
M. Antoine
41 Physiotherapy and Rehabilitation Programs for Pediatric VAD Patients
421(6)
C. VanderPluym
J. Conway
H. Buchholz
A. Lorts
42 Patient-and Device-Tailored Antithrombotic Treatment
427(6)
Vincenzo Tarzia
Giacomo Bortolussi
Jonida Bejko
Tomaso Bottio
Gino Gerosa
43 Coagulation Monitoring
433(12)
Alexander Stepanenko
Ivan Netuka
44 Outpatient Management: The Role of the VAD Coordinator and Remote Monitoring
445(22)
Dawn M. Christensen
Christina VanderPluym
Jennifer Conway
Angela Lorts
Holger Buchholz
Thomas Schloglhofer
Juliane Viericke
Alexander Stepanenko
Friedrich Kauffman
Gro Sorenson
45 Psychosocial Considerations of Mechanical Circulatory Support: Decision Making, Behavioral Evaluation, Quality of Life, Caregivers, and End of Life
467(12)
Kathleen L. Grady
Larry A. Allen
Paul W. Goetz
V Adverse Events Management
46 Ischemic and Hemorrhagic Stroke
479(10)
Rachel A. Beaupre
Jeffrey A. Morgan
47 Gastrointestinal Bleeding
489(6)
Anna L. Meyer
Ivan Netuka
48 Pump Thrombosis
495(18)
E. Potapov
F. Kaufmann
A.M. Scandroglio
M. Fieri
49 Infectious Complications
513(26)
Ezin Deniz
Christina Feldmann
Jan D. Schmitto
Margaret M. Hannan
50 Acquired von Willebrand Syndrome
539(6)
Anna L. Meyer
Ivan Netuka
51 Concomitant Noncardiac Surgery During Mechanical Circulatory Support: Management of Therapy
545(12)
Rachel A. Beaupre
Jeffrey A. Morgan
VI Miniaturization and Future Technologies
52 Novel HeartMate Cardiac Assist Systems (Thoratec)
557(8)
Edward J. Burke
Christopher Parker
53 HeartWare® HVAD® System
565(4)
Daniel Tamez
Katherine Chorpenning
Jeff A. LaRose
54 ReliantHeart: Forward Compatibility and TET
569(12)
Antonio Loforte
Lucio Careddu
Emanuela Angeli
Luca Ragni
Gaetano Gargiulo
Rodger G. Ford
55 Early Experience with the CARMAT Bioprosthetic Artificial Heart
581(8)
Piet Jansen
Christian Latremouille
Alain Carpentier
56 The ReinHeart Solution
589(6)
Gero Tenderich
Sotirios Spiliopoulos
Reiner Koerfer
VII Health-Economic Aspects
57 Health-Economic Aspects of MCS Therapy
595(12)
Robin Bostic
Mark S. Slaughter
VIII Registries Perspectives
58 The EUROMACS Registry of Patients Who Receive Mechanical Circulatory Support: Role and Perspectives
607(7)
Theo M.M.H. de By
Evaristo Castedo
Thomas Krabatsch
Paul Mohacsi
Bart P. Meyns
Ivan Netuka
Jan Gummert
Service Part
Telemonitoring and Teleconsultation
614
Dr. Antonio Loforte, MD, PhD 





Dr. Antonio Loforte received his Medical Degree from Catania University School of Medicine, Italy, and completed his cardiothoracic surgery residency at the University of Bologna, S. Orsola-Malpighi Hospital, Italy, after a period of training at St. Antonius Ziekenhuis, Nieuwegein, Utrecht, The Netherlands. He completed a two-year cardiothoracic and transplantation surgery fellowship at the Deutsches Herzzentrum Berlin, Germany, and then joined the  Michael E. DeBakey Department of Surgery, Division of Tranplant  and Assist Devices, Baylor College of Medicine, Houston, Texas, USA, and the Klinic fur Herzchirurgie, Universitat Leipizig, Herzzentrum, Leipizig.





He became permanent staff surgeon at S. Camillo Hospital, Department of Cardiac Surgery and Transplantation, Rome, Italy, and currently moved back as permanent staff surgeon to S. Orsola-Malpighi Hospital, Bologna University, Department of Cardiovascular Surgery and Transplantation, Italy.





Dr. Lofortes main clinical areas of interest are Heart Tranplantation, Mechanical Circulatory Support therapy, Aortic Surgery, Minimally-Invasive Heart Surgery, OPCABG and new technologies in cardiac surgery.





Dr. Lofortes main scientific and research areas of interest are Organ Transplantation and Mechanical Circulatory Support (ECMO, VAD, TAH).





He got a European PhD Label in Organ Transplantation awarded by Rome Tor Vergata University, Italy, and the dissertation title has been: "The role of Mechanical Circulatory Support in end-stage heart failure as bridge or alternative to Heart Transplantation".





He got, by time, 3 International Awards by such Societies as SITO, ASAIO and EACTS, respectively, on clinical reaserch studies focused on Mechanical Circulatory Support therapy.





He has published over 60 papers in peer-reviewed Journals, as well as 5 book chapters and he is author of more then 170 abstracts (communications) for International meetings. He is a reviewer for 19 International Journals and on the Editorial Board of 8.

He is active member of  SICCH, EACTS, ASAIO, ISHLT, RHICS, STS, EUROMACS.

Dr. Cristiano Amarelli, MD

Dr. Amarelli, is a cardiac nonacademic surgeon involved in the field of heart transplantation during the last 15 years with a strong scientific activity in the field of transplantation, mechanical valve and mechanical circulatory support. Born in Naples he graduated in Naples at the Second University of Naples where he completed in 2003 his training in cardiovascular surgery. He is an active promotor of heart donation for the European Cardiothoracic Transplant Association (ECTTA) stimulating and coordinating the writing process of the European Consensus Conference on thoracic donors, takes active part to the editorial board and to the historic committee of the ASAIO, and is active reviewer for manyjournals and international meetings. During last years undertake to a national network looking to expand the adoption of mechanical circulatory support in Italy under the auspices of National Transplant Center and of the Italian Society of Cardiac Surgery. Dr. Andrea Montalto, MD.





Dr. Andrea Montalto obtained his Medical Degree at Federico II University  School of Medicine in Neaples, Italy.







After completed the  residency  in cardiac surgery at the University Federico II, he moved to Rome to complete the training by attending the cardiac surgery center at  S. Camillo Hospital.





Since 2006 he became permanent staff surgeon  at S. Camillo Hospital, Department of Cardiac Surgery and Transplantation, Rome, Italy,





Dr. Montalto has shown particular interest in the field of surgical treatment of advanced heart failure becoming familiar in the management of patients implantedwith mechanical devices.





Dr.Montalto, since 2012, has acquired the role of head of the VAD program at the center of cardiac surgery at the San Camillo Hospital.





He is active member of SICCH, EUROMACS.

Prof. hc. Dr. med. habil. Thomas Krabatsch

Thomas Krabatsch, MD, PhD is Senior Cardiac Surgeon at Deutsches Herzzentrum Berlin. Dr. Krabatsch has expertise in the surgical treatment of a variety of cardiovascular diseases in adults including severe diffuse coronary artery disease, valvular heart diseases, mechanical circulatory support and transplantation. He is the Director of Deutsches Herzzentrum Berlin's mechanical circulatory support team, which has experience with over 2,800 implants. Dr. Krabatsch's basic science research interests include endothelial growth factors for coronary disease and gene transfer, laser therapy and cell therapy. He is Member of the ISHLT, EACTS, DGTHG, German society for Gene Therapy, BBGHK, and author or coauthor of more than 150 scientific articles. Dr. Krabatsch also has relations with several universities and cardio-surgical hospitals in Eastern Europe, such as Russia, Belarus, Bosnia and Hungary. He is Honorary Professor in one of Russia's largest medical schools.